A nonmainstream approach against cancer

References

• Shaywitz D, Taleb N. Drug research needs serendipity. Financial Times; July 30, 2008.
   Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Gatenby RA. A change of strategy in the war on cancer. Nature 2009;459:508–9.
   PubMed Web of Science ®Google Scholar
• Benjamin DJ. The efficacy of surgical treatment of cancer – 20 years later. Med Hypoth 2014;82:412–20.
   PubMed Web of Science ®Google Scholar
• Ban TA. The role of serendipity in drug discovery. Dialog Clin Neurosci 2006;8:335–44.
   PubMedGoogle Scholar
• Campillos M, Kuhn M, Gavin AC, et al. Drug target identification using side-effect similarity. Science 2008;321:263–6.
   PubMed Web of Science ®Google Scholar
• Luciani F, Spada M, De Milito A, et al. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst 2004;96:1702–13.
   PubMed Web of Science ®Google Scholar
• De Milito A, Iessi E, Logozzi MA, et al. Proton pump inhibitors induce apoptosis of human B cell tumors through a caspase-independent mechanism involving reactive oxygen species. Cancer Res 2007;67:5408–17.
   PubMed Web of Science ®Google Scholar
• Fais S, De Milito A, You H, Qin W. Targeting vacuolar H+-ATPases as a new strategy against cancer. Cancer Res 2007;67:10627–30.
   PubMed Web of Science ®Google Scholar
• De Milito A, Canese R, Marino ML, et al. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer 2010;127:207–19.
   PubMed Web of Science ®Google Scholar
• Fais S. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism. J Intern Med 2010;267:515–25.
   PubMed Web of Science ®Google Scholar
• Spugnini E, Baldi A, Buglioni S, et al. Lansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors. J Transl Med 2011;9:221. doi: 10.1186/1479-5876-9-221.
   PubMed Web of Science ®Google Scholar
• Spugnini EP, Sonveaux P, Stock C, et al. Proton channels and exchangers in cancer. Biochim Biophys Acta 2015;1848:2715–26.
   PubMed Web of Science ®Google Scholar
• Fais S, Venturi G, Gatenby B. Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy. Cancer Metastasis Rev 2014;33:1095–108.
   PubMed Web of Science ®Google Scholar
• Lugini L, Matarrese P, Tinari A, et al. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells. Cancer Res 2006;66:3629–38.
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science (New York, N.Y.) 1956;123:309–14.
   PubMed Web of Science ®Google Scholar
• De Milito A, Fais S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol 2005;1:779–86.
   PubMedGoogle Scholar
• Federici C, Petrucci F, Caimi S, et al. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS One 2014;9:e88193. doi: 10.1371/journal.pone.0088193.
   PubMed Web of Science ®Google Scholar
• Azzarito T, Venturi G, Cesolini A, Fais S. Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma. Cancer Lett 2015;356:697–703.
   PubMed Web of Science ®Google Scholar
• Ferrari S, Perut F, Fagioli F, et al. Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed. J Transl Med 2013;11:268. doi: 10.1186/1479-5876-11-268.
   PubMed Web of Science ®Google Scholar
• Spugnini EP, Buglioni S, Carocci F, et al. High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors. J Transl Med 2014;12:225. doi: 10.1186/s12967-014-0225-y.
   PubMed Web of Science ®Google Scholar
• Ibrahim-Hashim A, Cornnell HH, Abrahams D, et al. Systemic buffers inhibit carcinogenesis in TRAMP mice. J Urol 2012;188:624–31.
   PubMed Web of Science ®Google Scholar
• Huber V, De Milito A, Harguindey S, et al. Proton dynamics in cancer. J Transl Med 2010;8:57. doi: 10.1186/1479-5876-8-57.
   PubMed Web of Science ®Google Scholar
• Harguindey S, Arranz JL, Wahl ML, et al. Proton transport inhibitors as potentially selective anticancer drugs. Anticancer Res 2009;29:2127–36.
   PubMed Web of Science ®Google Scholar
• Fais S. Cannibalism: a way to feed on metastatic tumors. Cancer Lett 2007;258:155–64.
   PubMed Web of Science ®Google Scholar
• Fais S, Fauvarque MO. TM9 and cannibalism: how to learn more about cancer by studying amoebae and invertebrates. Trends Mol Med 2012;18:4–5.
   PubMed Web of Science ®Google Scholar
• Tauber AI. Metchnikoff and the phagocytosis theory. Nat Rev Mol Cell Biol 2003;4:897–901.
   PubMed Web of Science ®Google Scholar
• Lozupone F, Perdicchio M, Brambilla D, et al. The human homologue of Dictyostelium discoideum phg1A is expressed by human metastatic melanoma cells. EMBO Rep 2009;10:1348–54.
   PubMed Web of Science ®Google Scholar
• Lozupone F, Borghi M, Marzoli F, et al. TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells. Oncogene 2015;34:5163–74.
   PubMed Web of Science ®Google Scholar
• Overholtzer M, Mailleux AA, Mouneimne G, et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 2007;131:966–79.
   PubMed Web of Science ®Google Scholar
• Tun NM, Guevara E. Emperipolesis. Am J Med Sci 2015;350:484. doi: 10.1097/MAJ.0000000000000415.
   Web of Science ®Google Scholar
• Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol 1969;87:63–70.
   PubMedGoogle Scholar
• Benseler V, Warren A, Vo M, et al. Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc Natl Acad Sci USA 2011;108:16735–40.
   PubMed Web of Science ®Google Scholar
• Salvesen GS. Dying from within: granzyme B converts entosis to emperitosis. Cell Death Different 2014;21:3–4.
   PubMed Web of Science ®Google Scholar
• Andreola G, Rivoltini L, Castelli C, et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 2002;195:1303–16.
   PubMed Web of Science ®Google Scholar
• Huber V, Fais S, Iero M, et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 2005;128:1796–804.
   PubMed Web of Science ®Google Scholar
• Parolini I, Federici C, Raggi C, et al. Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 2009;284:34211–22.
   PubMed Web of Science ®Google Scholar
• Logozzi M, De Milito A, Lugini L, et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One 2009;4:e5219. doi: 10.1371/journal.pone.0005219.
   PubMed Web of Science ®Google Scholar
• Properzi F, Logozzi M, Fais S. Exosomes: the future of biomarkers in medicine. Biomark Med 2013;7:769–78.
   PubMed Web of Science ®Google Scholar
• Zocco D, Ferruzzi P, Cappello F, et al. Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugs. Front Oncol 2014;4:267.
   PubMedGoogle Scholar
• Canitano A, Venturi G, Borghi M, et al. Exosomes released in vitro from Epstein–Barr virus (EBV)-infected cells contain EBV-encoded latent phase mRNAs. Cancer Lett 2013;337:193–9.
   PubMed Web of Science ®Google Scholar
• Properzi F, Logozzi M, Abdel-Haq H, et al. Detection of exosomal prions in blood by immunochemistry techniques. J Gen Virol 2015;96:1969–74.
   PubMed Web of Science ®Google Scholar
• Capobianchi MR, Fais S, Ameglio F, et al. A simple and reliable method to detect cell membrane proteins on infectious human immunodeficiency virus type 1 particles. J Infect Dis 1994;169:886–9.
   PubMed Web of Science ®Google Scholar
• Fais S, Capobianchi MR, Abbate I, et al. Unidirectional budding of HIV-1 at the site of cell-to-cell contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral matrix protein. AIDS 1995;9:329–35.
   PubMed Web of Science ®Google Scholar
• Fais S, Burgio L, Capobianchi MR, et al. The biological relevance of polykarions in the immune response. Immunol Today 1997;18:522–6.
   PubMedGoogle Scholar
• Nguyen DG, Booth A, Gould SJ, Hildreth JE. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J Biol Chem 2003;278:52347–54.
   PubMed Web of Science ®Google Scholar
• Wiley RD, Gummuluru S. Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc Natl Acad Sci USA 2006;103:738–43.
   PubMed Web of Science ®Google Scholar
• Cossetti C, Lugini L, Astrologo L, et al. Soma-to-germline transmission of RNA in mice xenografted with human tumour cells: possible transport by exosomes. PLoS One 2014;9:e101629. doi: 0.1371/journal.pone.0101629.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654–9.
   PubMed Web of Science ®Google Scholar
• Challagundla KB, Wise PM, Neviani P, et al. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst 2015;107:pii: djv135. doi: 10.1093/jnci/djv135.
   PubMedGoogle Scholar
• Fall K, Fang F, Mucci LA, et al. Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Med 2009;6:e1000197. doi: 10.1371/journal.pmed.1000197.
   PubMed Web of Science ®Google Scholar
• Rauch C, Pluen A. Multi drug resistance-dependent “vacuum cleaner” functionality potentially driven by the interactions between endocytosis, drug size and Pgp-like transporters surface density. Eur Biophys J 2007;36:121–31.
   PubMed Web of Science ®Google Scholar
• Rauch C. Toward a mechanical control of drug delivery. On the relationship between Lipinski's 2nd rule and cytosolic pH changes in doxorubicin resistance levels in cancer cells: a comparison to published data. Eur Biophys J 2009;38:829–46.
   PubMed Web of Science ®Google Scholar
• Rauch C. On the relationship between drug's size, cell membrane mechanical properties and high levels of multi drug resistance: a comparison to published data. Eur Biophys J 2009;38:537–46.
   PubMed Web of Science ®Google Scholar
• Wang BY, Zhang J, Wang JL, et al. Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer. J Exp Clin Cancer Res 2015;34:85. doi: 10.1186/s13046-015-0194-x.
   PubMed Web of Science ®Google Scholar
• Pepper JW. Defeating pathogen drug resistance: guidance from evolutionary theory. Evolution 2008;62:3185–91.
   PubMed Web of Science ®Google Scholar
• Alfarouk KO, Shayoub ME, Muddathir AK, et al. Evolution of tumor metabolism might reflect carcinogenesis as a reverse evolution process (dismantling of multicellularity). Cancers (Basel) 2011;3:3002–17.
   PubMedGoogle Scholar
• Alfarouk KO, Verduzco D, Rauch C, et al. Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question. Oncoscience 2014;1:777–802.
   PubMedGoogle Scholar